Treatment of Hyponatremia
The treatment of hyponatremia should be tailored to the underlying volume status, severity of symptoms, and chronicity of the condition, with careful attention to correction rates to prevent osmotic demyelination syndrome. 1
Classification and Diagnosis
Hyponatremia is defined as serum sodium concentration below 135 mmol/L, with treatment generally considered when levels fall below 130 mmol/L. Proper management requires determining:
- Volume status: Hypovolemic, euvolemic, or hypervolemic
- Severity: Mild (130-134 mmol/L), moderate (125-129 mmol/L), severe (<125 mmol/L)
- Chronicity: Acute (<48 hours) vs chronic (>48 hours)
- Symptoms: Mild (nausea, headache, weakness) vs severe (seizures, coma, altered mental status)
Laboratory Assessment
| Volume Status | Urine Osmolality | Urine Sodium | Suggested Diagnosis |
|---|---|---|---|
| Hypovolemic | Variable | <20 mEq/L | Volume depletion |
| Euvolemic | >500 mOsm/kg | >20-40 mEq/L | SIADH |
| Hypervolemic | Elevated | <20 mEq/L | Heart failure, cirrhosis |
Treatment Algorithm
1. Severe Symptomatic Hyponatremia (Emergency)
- Presentation: Seizures, coma, severe neurological symptoms
- Treatment:
- Administer 3% hypertonic saline as 100-150 mL bolus or continuous infusion 1, 2
- Target correction: 4-6 mEq/L in first 6 hours or until symptoms improve 1
- Maximum correction: 8 mEq/L in 24 hours, not exceeding 12 mEq/L in 24 hours 3, 1
- Monitor serum sodium every 2-4 hours during active correction 1
- If correction exceeds safe limits, consider desmopressin or hypotonic fluids to prevent ODS 1
2. Hypovolemic Hyponatremia
- Presentation: Clinical signs of dehydration, orthostatic hypotension
- Treatment:
3. Euvolemic Hyponatremia (often SIADH)
- Treatment:
Mild to moderate (asymptomatic):
Refractory cases:
4. Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
- Treatment:
- Fluid restriction to 1,000 mL/day for moderate hyponatremia (120-125 mEq/L) 3
- More severe fluid restriction with albumin infusion for severe hyponatremia (<120 mEq/L) 3
- Treat underlying condition (heart failure, cirrhosis)
- Loop diuretics may be needed for volume management 1
- Consider tolvaptan for short-term use in refractory cases 1, 4
Critical Considerations
Correction Rates
- Chronic hyponatremia: Maximum 8 mEq/L in 24 hours 3, 1
- Acute hyponatremia (<48 hours): Can be corrected more rapidly at 1 mEq/L/hour 3
- High-risk patients (alcoholism, malnutrition, liver disease): Lower correction rate of 4-6 mEq/L per day 3
Osmotic Demyelination Syndrome (ODS)
- Risk factors: Chronic hyponatremia, alcoholism, liver disease, malnutrition, hypokalemia 3
- Symptoms: Dysarthria, dysphagia, altered mental status, quadriparesis 3
- Prevention: Avoid correction exceeding 8 mEq/L in 24 hours 3, 1
- Management of overcorrection: Administration of hypotonic fluids or desmopressin 1, 2
Special Populations
- Cirrhosis patients: Hyponatremia reflects worsening hemodynamic status and increases risk of complications 3
- Neurosurgical patients: At higher risk of complications from hyponatremia, with prevalence as high as 50% 3
- Subarachnoid hemorrhage: Consider fludrocortisone to prevent natriuresis 1
Medication Considerations
- Discontinue medications that may cause or worsen hyponatremia (SSRIs, carbamazepine, thiazide diuretics, NSAIDs) 1
- Tolvaptan: Effective for euvolemic and hypervolemic hyponatremia but should be used short-term 4
- Albumin: Consider for hypervolemic hyponatremia in cirrhosis 3
- Hypertonic saline: Reserved for symptomatic or severe hyponatremia 5
By following this structured approach to hyponatremia management based on volume status, symptom severity, and chronicity, clinicians can effectively treat this common electrolyte disorder while minimizing the risk of complications.